首页 › 基金 › Vestal Point Capital, LP › RGEN
Vestal Point Capital, LP 对 RGEN 的持仓历史
REPLIGEN CORP · 医疗保健
Vestal Point Capital, LP 在 Q2 2026 的 13F 申报中披露持有 RGEN(REPLIGEN CORP)400,000 股,市值约 US$54.6M,约占其申报组合的 1.28%,在其申报持仓中市值排名第 27 位。 Vestal Point Capital, LP 最近 4 个申报季度中有 4 个季度披露了 RGEN 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Vestal Point Capital, LP 对 RGEN 的持仓演变
Vestal Point Capital, LP 于 Q3 2025 首次披露 RGEN 持仓:400,000 股(约 US$53.5M)。 该持仓在 Q1 2026 达到峰值 925,000 股,市值约 US$109.0M。 在 4 次申报中,Vestal Point Capital, LP 1 次增持、2 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 400,000 股、市值约 US$54.6M,环比减持 -525,000 股。。 持仓曾出现大幅变动:Q4 2025 减持约 79% (随后一个季度股价下跌 28%)、Q1 2026 增持约 1014% (随后一个季度股价上涨 16%)、Q2 2026 减持约 57% (随后一个季度股价上涨 41%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 400.00K | $53.47M | 新进 |
| Q4 2025 | 83.00K | $13.60M | 减持 |
| Q1 2026 | 925.00K | $108.98M | 增持 |
| Q2 2026 | 400.00K | $54.58M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RGEN 与 13F 数据
RGEN(REPLIGEN CORP)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 RGEN,申报仓位最大的包括:UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$380.8M), Maverick 资本 (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RGEN 的基金
- UNITED CAPITAL FINANCIAL ADVISORS, LLC 2.79M 股 · $380.76M · Q2 2026
- Maverick 资本 1.98M 股 · $270.77M · Q2 2026
- MAVERICK CAPITAL LTD 1.98M 股 · $270.77M · Q2 2026
- CONGRESS ASSET MANAGEMENT CO 1.02M 股 · $196.25M · Q3 2026
- WASATCH ADVISORS LP 907.16K 股 · $174.38M · Q3 2026
- RTW INVESTMENTS, LP 1.24M 股 · $169.27M · Q2 2026
- Conestoga Capital Advisors, LLC 980.98K 股 · $133.85M · Q2 2026
- Stephens Investment Management Group LLC 937.08K 股 · $127.86M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 733.74K 股 · $100.11M · Q2 2026
- DeepCurrents Investment Group LLC 94.44M 股 · $96.80M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 656.09K 股 · $89.52M · Q2 2026
- Aequim Alternative Investments LP 75.00M 股 · $77.09M · Q2 2026
更多关于 Vestal Point Capital, LP
常见问题
How long has Vestal Point Capital, LP held RGEN?
Vestal Point Capital, LP has disclosed RGEN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Vestal Point Capital, LP's current position in RGEN?
As of Q2 2026, Vestal Point Capital, LP holds 400.00K shares of RGEN (REPLIGEN CORP), valued at $54.58M, representing 1.28% of its reported portfolio and ranking #27.
Has Vestal Point Capital, LP been buying or selling RGEN?
In the latest 13F filing (Q2 2026), Vestal Point Capital, LP reduced its position in RGEN. The position peaked in Q1 2026 at 925.00K shares.
Which other funds hold RGEN?
Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick 资本, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.